Loading the content... Loading depends on your connection speed!



Researchers Launch First-Ever Phase II Safety Study of a Rectal Microbicide to Prevent HIV

PITTSBURGH, Oct. 2, 2013 – Taking an important step toward the development of a product to prevent HIV infections associated with unprotected anal sex, researchers today announced the launch of a global Phase II clinical trial of a potential rectal
Read More

Why is No One on The First Treatment to Prevent H.I.V.?

In November, 2010, the New England Journal of Medicine published the results of a three-year clinical trial, funded by the National Institutes of Health, announcing the arrival of a treatment that could reduce the risk of contracting H.I.V. by more
Read More

Mobile version: Enabled